Last update 02 May 2024
Shanghai Sinovent Biopharmaceutical Co., Ltd
2022|
Shanghai Shi, China
Last update 02 May 2024
Overview
Basic Info
Introduction Founded in 2017, Shanghai Sinovent Biopharmaceutical Co., Ltd. is a biopharmaceutical enterprise that integrates scientific research prowess with commercialization expertise to form a platform-based model for novel drug development. Harnessing proprietary advancements in targeted therapies, anti-infectives, and PROTAC technology platforms, Xinovi has established an innovative pipeline of drug candidates, including BLI inhibitors, EZH2 inhibitors, hURAT1 inhibitors, and next-generation Antibody-Drug Conjugates (ADCs). These developments target a spectrum of therapeutic areas, including oncology, infectious diseases, and metabolic disorders. |
Tags
Neoplasms
Endocrinology and Metabolic Disease
Respiratory Diseases
Antibody drug conjugate (ADC)
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
一项评估XNW28012治疗晚期实体瘤患者的安全性、耐受性、药代动力学和初步抗肿瘤活性的开放性、多中心I/II期临床研究
[Translation] An open-label, multicenter Phase I/II clinical study to evaluate the safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of XNW28012 in patients with advanced solid tumors
XNW27011在局部晚期或转移性实体瘤患者中的首次人体Ⅰ/Ⅱ期研究
[Translation] First-in-human phase I/II study of XNW27011 in patients with locally advanced or metastatic solid tumors
100 Clinical Results associated with Shanghai Sinovent Biopharmaceutical Co., Ltd
Login to view more data
Login to view more data
100 Deals associated with Shanghai Sinovent Biopharmaceutical Co., Ltd
Login to view more data
100 Translational Medicine associated with Shanghai Sinovent Biopharmaceutical Co., Ltd
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 05 Jul 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free